• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌检测。捷克斯洛伐克一项随机前瞻性研究的结果。

Lung cancer detection. Results of a randomized prospective study in Czechoslovakia.

作者信息

Kubík A, Polák J

出版信息

Cancer. 1986 Jun 15;57(12):2427-37. doi: 10.1002/1097-0142(19860615)57:12<2427::aid-cncr2820571230>3.0.co;2-m.

DOI:10.1002/1097-0142(19860615)57:12<2427::aid-cncr2820571230>3.0.co;2-m
PMID:3697941
Abstract

A randomized prospective study of lung cancer detection was begun in 1976 to evaluate semiannual screening by radiologic and sputum cytologic study in comparison to screening at a 3-year interval, and to no screening. In a high-risk population of 6364 men (aged 40 to 64 years), the initial prevalence of lung cancer was 0.28% (18 cases), the annual incidence was 0.35% per year (66 cases during 3 years), the proportion of Stage I cases was 31% (26/84), and Stage II was 17% (14/84), "curative" resections were 27% (23/84), and 5-year survival was 23% (19/84). The study confirmed the ability of radiologic screening to detect lung cancer at an earlier stage when treatment by resection can be accomplished. The fate of a high-risk population submitted to screening was better than that of a population with no screening where lung cancer was discovered by symptoms, accidental x-rays, or at autopsy. A matter of lesser importance was the frequency of screening. The absolute numbers of 5-year survivors detected by screening were practically the same for either compared screening frequency.

摘要

1976年开展了一项关于肺癌检测的随机前瞻性研究,以评估每半年进行一次放射学和痰细胞学检查筛查与每3年进行一次筛查以及不进行筛查相比的效果。在6364名年龄在40至64岁之间的高危男性人群中,肺癌的初始患病率为0.28%(18例),年发病率为每年0.35%(3年期间66例),I期病例的比例为31%(26/84),II期为17%(14/84),“根治性”切除率为27%(23/84),5年生存率为23%(19/84)。该研究证实了放射学筛查能够在可通过切除进行治疗的早期阶段检测出肺癌。接受筛查的高危人群的预后比未进行筛查、通过症状、偶然的X光检查或尸检发现肺癌的人群要好。筛查频率是一个不太重要的问题。对于两种比较的筛查频率,通过筛查检测出的5年幸存者的绝对数量实际上是相同的。

相似文献

1
Lung cancer detection. Results of a randomized prospective study in Czechoslovakia.肺癌检测。捷克斯洛伐克一项随机前瞻性研究的结果。
Cancer. 1986 Jun 15;57(12):2427-37. doi: 10.1002/1097-0142(19860615)57:12<2427::aid-cncr2820571230>3.0.co;2-m.
2
Lung cancer screening results in the National Cancer Institute New York study.美国国立癌症研究所纽约研究中的肺癌筛查结果。
Cancer. 2000 Dec 1;89(11 Suppl):2356-62. doi: 10.1002/1097-0142(20001201)89:11+<2356::aid-cncr8>3.3.co;2-q.
3
Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia.对肺癌进行半年一次筛查无获益:捷克斯洛伐克高危男性人群随机对照试验的随访报告
Int J Cancer. 1990 Jan 15;45(1):26-33. doi: 10.1002/ijc.2910450107.
4
Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment.捷克肺癌筛查研究:自入组以来长达15年的肺癌死亡病例试验后随访。
Cancer. 2000 Dec 1;89(11 Suppl):2363-8. doi: 10.1002/1097-0142(20001201)89:11+<2363::aid-cncr9>3.3.co;2-n.
5
The role of radiologic screening in lung cancer.放射学筛查在肺癌中的作用。
Radiol Clin North Am. 1990 May;28(3):489-95.
6
The natural history of lung cancer estimated from the results of a randomized trial of screening.根据一项肺癌筛查随机试验结果估算的肺癌自然史。
Cancer Causes Control. 1992 Mar;3(2):115-23. doi: 10.1007/BF00051651.
7
Lung cancer screening: the Mayo program.肺癌筛查:梅奥计划。
J Occup Med. 1986 Aug;28(8):746-50. doi: 10.1097/00043764-198608000-00038.
8
Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study.
Am Rev Respir Dis. 1984 Oct;130(4):549-54. doi: 10.1164/arrd.1984.130.4.549.
9
Survival and mortality in a randomized study of lung cancer detection.肺癌检测随机研究中的生存率和死亡率
Neoplasma. 1990;37(4):467-75.
10
Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study.早期肺癌检测:纪念斯隆-凯特琳研究所研究中初始(患病率)放射学和细胞学筛查的结果
Am Rev Respir Dis. 1984 Oct;130(4):555-60. doi: 10.1164/arrd.1984.130.4.555.

引用本文的文献

1
Artificial Intelligence and Early Detection of Breast, Lung, and Colon Cancer: A Narrative Review.人工智能与乳腺癌、肺癌和结肠癌的早期检测:一项叙述性综述。
Cureus. 2025 Feb 18;17(2):e79199. doi: 10.7759/cureus.79199. eCollection 2025 Feb.
2
Do we know enough about the effect of low-dose computed tomography screening for lung cancer on mortality to act? An updated systematic review, meta-analysis and network meta-analysis of randomised controlled trials 2017 to 2021.我们对低剂量计算机断层扫描筛查肺癌对死亡率的影响了解得足够多,可以采取行动了吗?2017年至2021年随机对照试验的最新系统评价、荟萃分析和网状荟萃分析。
Diagn Progn Res. 2023 Dec 11;7(1):26. doi: 10.1186/s41512-023-00162-0.
3
Effective lung cancer control: An unaccomplished challenge in cancer research.
有效的肺癌控制:癌症研究中一项尚未完成的挑战。
Cytojournal. 2023 Aug 7;20:16. doi: 10.25259/Cytojournal_36_2022. eCollection 2023.
4
Highly sensitive noninvasive early lung cancer detection using DNA methylation topology in sputum-derived epithelial cells.利用痰液来源上皮细胞中的DNA甲基化拓扑结构进行高灵敏度非侵入性早期肺癌检测。
JTCVS Open. 2022 Dec 10;13:389-410. doi: 10.1016/j.xjon.2022.11.018. eCollection 2023 Mar.
5
Artificial Intelligence in Lung Cancer Imaging: Unfolding the Future.肺癌成像中的人工智能:展现未来
Diagnostics (Basel). 2022 Oct 31;12(11):2644. doi: 10.3390/diagnostics12112644.
6
Advances in lung cancer screening and early detection.肺癌筛查与早期检测的进展
Cancer Biol Med. 2022 May 11;19(5):591-608. doi: 10.20892/j.issn.2095-3941.2021.0690.
7
Lung Cancer Screening: Review and 2021 Update.肺癌筛查:综述与2021年更新
Curr Pulmonol Rep. 2022;11(1):15-28. doi: 10.1007/s13665-021-00283-1. Epub 2022 Apr 2.
8
The challenges of implementing low-dose computed tomography for lung cancer screening in low- and middle-income countries.在低收入和中等收入国家实施低剂量计算机断层扫描进行肺癌筛查的挑战。
Nat Cancer. 2020 Dec;1(12):1140-1152. doi: 10.1038/s43018-020-00142-z. Epub 2020 Nov 30.
9
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer.支气管灌洗液的分子检测用于肺癌的诊断和预测评估。
Mol Oncol. 2020 Sep;14(9):2163-2175. doi: 10.1002/1878-0261.12713. Epub 2020 Jun 24.
10
High Aldehyde Dehydrogenase Levels Are Detectable in the Serum of Patients with Lung Cancer and May Be Exploited as Screening Biomarkers.肺癌患者血清中可检测到高醛脱氢酶水平,其或可作为筛查生物标志物。
J Oncol. 2019 Aug 22;2019:8970645. doi: 10.1155/2019/8970645. eCollection 2019.